KEY PRODUCTS
With Fermion, start the journey of your innovative API.
01 1Fermion Oy
01 1NINTEDANIB ESYLATE
01 1Finland
01 1Active
01 1Complete
With Fermion, start the journey of your innovative API.
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-26
Pay. Date : 2018-12-20
DMF Number : 33361
Submission : 2019-01-02
Status : Active
Type : II
20
Fermion Oy, based in Finland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for With Fermion, start the journey of your innovative API.
One of their notable products is NINTEDANIB ESYLATE, with a corresponding US DMF Number 33361.
Remarkably, this DMF maintains an Active status since its submission on January 02, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 26, 2019, and payment made on December 20, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
